L. Jullien, J.-F. Allemand et al.
FULL PAPER
0.55 mmol). Compound BiBi was obtained as pale yellow plates (172 mg,
83%). M.p. 2208C (ref. [68] 218 2208C); 1H NMR (250 MHz, CDCl3,
258C, TMS):d=6.95 (s, 1H), 7.37 7.54 (m, 6H), 7.57 7.82 (m, 8H), 8.04
8.13 (m, 4H), 14.58 14.76 ppm (m, 1H); 13C NMR (63 MHz, CDCl3,
258C, TMS): d=93.2, 127.3, 127.4, 127.8, 128.2, 129.0, 134.4, 140.0, 145.3,
185.3 ppm.
under reflux for 2 h, concentrated hydrochloric acid (0.5 mL) was added
to the mixture. Reflux was continued for 5 min and water (5 mL) was
added. After evaporation of the solvent, the crude residue was purified
by CC (C6H12/CH2Cl2 75:25 to 30:70) to yield BiPhe as a white solid
(620 mg, 21%). M.p. 1118C (ref. [69] 1128C); 1H NMR (250 MHz,
CDCl3, 258C, TMS): d=6.91 (s, 1H), 7.37 7.63 (m, 8H), 7.60 7.70 (m,
2H), 7.68 7.78 (m, 4H), 7.93 8.12 (m, 4H), 14.73 ppm (brs, 1H); 13C
NMR (63 MHz, CDCl3, 258C, TMS): d=93.1, 127.0, 127.15, 127.2,
127.25, 127.3, 127.7, 128.1, 128.2, 128.7, 128.9, 128.95, 130.1, 132.4, 134.3,
135.6, 139.9, 145.2, 145.6, 185.3, 185.7 ppm.
1-(Biphenyl-4’-yl)-3-(2-naphthyl)propane-1,3-dione (BiNa): Same method
as for NaPhe, but with ethyl 3-(2-naphthyl)-3-oxo-2-(biphenyl-4-carbon-
yl) propionate (336 mg, 0.8 mmol). Compound BiNa was obtained as col-
orless crystals after recrystallization in ethanol (140 mg, 50%). 1H NMR
(250 MHz, CDCl3, 258C, TMS): d=7.06 (s, 1H), 7.37 7.72 (m, 7H), 7.75
(d, 3J(H,H)=8.4 Hz, 2H), 7.86 8.10 (m, 4H), 8.13 (d, 3J(H,H)=8.4 Hz,
2H), 8.57 (brs, 1H), 14.60 ppm (brs, 1H); 13C NMR (63 MHz, CDCl3,
258C, TMS): d=64.7, 123.9, 127.1, 127.3, 127.6, 127.9, 128.5, 129.0, 129.1,
129.3, 129.8, 130.7, 132.5, 133.1, 134.4, 136.0, 139.6, 146.7, 165.8, 190.3,
190.6 ppm.
Syntheses of the diketones Ar1Ar2 alongpathway C
1,3-Di(4-methoxyphenyl)propane-1,3-dione (MeOPheMeOPhe):[28] A sus-
pension of 4-methoxybenzoyl chloride (1.67 g, 9.8 mmol) and aluminium
chloride (1.4 g, 10.25 mmol) in tetrachloroethane (5 mL) was stirred at
558C for 2 h. Then, ethenyl acetate (430 mg, 5 mmol) was added and the
mixture was further stirred at 558C for 20 h. After cooling to room tem-
perature, hydrochloric acid (2m, 2 mL) and water (20 mL) were succes-
sively added. After extraction with ethyl acetate, the organic phase was
washed with sodium hydrogencarbonate and water. After drying (magne-
sium sulfate) and filtration, the organic solvent was evaporated to yield
MeOPheMeOPhe as pale yellow crystals after recrystallization in ethanol
(357 mg, 25%). M.p. 1148C (ref. [28] 116 1178C); 1H NMR (250 MHz,
CDCl3, 258C, TMS): d=3.89 (s, 6H), 6.74 (s, 1H), 6.93 7.02 (m, 4H),
7.92 8.01 ppm (m, 4H); 13C NMR (63 MHz, CDCl3, 258C, TMS): d=
55.5, 91.5, 114.0, 128.2, 129.1, 131.4, 163.0, 184.6 ppm.
(4’-Methoxybiphenylyl)-3-phenylpropane-1,3-dione (MeOBiPhe): Same
method as for NaPhe, but with ethyl benzoyl-4-methoxybenzoyl acetate
(1.08 g, 2.7 mmol). Compound MeOBiPhe was obtained as pale yellow
crystals after recrystallization in ethanol (515 mg, 57%). M.p. 1768C; 1H
NMR (250 MHz, CDCl3, 258C, TMS): d=3.87 (s, 3H), 6.90 (s, 1H),
6.98 7.06 (m, 2H), 7.44 7.66 (m, 5H), 7.65 7.72 (m, 2H), 7.97 8.09 ppm
(m, 4H); 13C NMR (63 MHz, CDCl3, 258C, TMS): d=55.4, 93.0, 114.4,
126.7, 127.2, 127.8, 128.3, 128.7, 132.3, 132.4, 133.6, 135.7, 144.8, 159.9,
185.4, 185.5 ppm; MS (CI, NH3): m/z (%): 348 (2) [M++18], 331 (100)
[M++1]; elemental analysis calcd (%) for C22H18O3 (330): C 79.98, H
5.49; found: C 79.82, H 5.69.
Syntheses of the Ar1Ar2BF2 compounds
Compound 1: A solution of BiBi (276 mg, 0.73 mmol) and BF3/Et2O
(0.14 mL, 1.1 mmol) in benzene (2 mL) was heated to reflux for 1 h.[21]
After evaporation of the solvent, 1 was obtained as yellow crystals after
recrystallization in benzene (230 mg, 74%). M.p. >2908C; 1H NMR
(250 MHz, CDCl3, 258C, TMS): d=7.28 (s, 1H), 7.40 7.57 (m, 6H), 7.66
7.72 (m, 4H), 7.76 7.84 (m, 4H), 8.21 8.31 ppm (m, 4H); 13C NMR
(63 MHz, CDCl3, 258C, TMS): d=93.3, 127.4, 127.8, 128.9, 129.1, 129.6,
130.8, 139.2, 148.1, 182.4 ppm; 19F NMR (235 MHz, CDCl3, 258C, CFCl3):
d=ꢀ140.24 (75%), ꢀ140.17 ppm (25%); MS (CI, NH3): m/z (%): 442
(100) [M++18], 405 (18), 361 (5); elemental analysis calcd (%) for
C27H19BF2O2 (424): C 76.44, H 4.51; found: C 76.45, H 4.51.
1-(4-Methoxyphenyl)-3-phenylpropane-1,3-dione (MeOPhePhe): Same
method as for NaPhe, but with ethyl benzoyl 4-methoxybenzoyl acetate
(654 mg, 2 mmol). Compound MeOPhePhe was obtained as colorless
crystals after recrystallization in ethanol (393 mg, 77%). M.p. 1378C; 1H
NMR (250 MHz, CDCl3, 258C, TMS): d=3.89 (s, 3H), 6.80 (s, 1H),
6.95 7.04 (m, 2H), 7.43 7.60 (m, 3H), 7.94 8.06 ppm (m, 4H); 13C NMR
(63 MHz, CDCl3, 258C, TMS): d=55.5, 92.4, 114.0, 127.0, 128.2, 128.6,
129.3, 132.1, 135.6, 163.3, 184.0, 186.2 ppm; MS (CI, NH3): m/z (%): 272
(21) [M++18], 256 (37) [M++2], 255 (100) [M++1]; elemental analysis
calcd (%) for C16H14O3 (254): C 75.57, H 5.55; found: C 75.56, H 5.65.
1,3-Di(2-naphthyl)propane-1,3-dione (NaNa): Same method as for
NaPhe, but with ethyl di(naphthalene-2-carbonyl) acetate (792 mg,
2 mmol). Compound NaNa was obtained as colorless crystals after recrys-
tallization in ethanol (501 mg, 77%). M.p. 1718C (ref. [69] 1728C); 1H
NMR (250 MHz, CDCl3, 258C, TMS): d=7.16 (s, 1H), 7.51 7.68 (m,
4H), 7.84 8.20 (m, 8H), 8.60 (brs, 2H), 14.58 ppm (brs, 1H); 13C NMR
(63 MHz, CDCl3, 258C, TMS): d=93.6, 123.3, 126.6, 127.6, 128.2, 128.4,
128.5, 129.4, 132.8, 132.9, 135.4, 185.6 ppm.
Compound 2: Same procedure as for 1, but with BiNa (140 mg,
0.4 mmol) and BF3/Et2O (0.05 mL, 1.1 mmol). 2 was obtained as yellow
1
crystals after recrystallization in benzene (113 mg, 71%). M.p. 2588C; H
NMR (250 MHz, CDCl3, 258C, TMS): d=7.39 (s, 1H), 7.43 7.57 (m,
3H), 7.57 7.64 (m, 4H), 7.82 (d, 3J(H,H)=8.5 Hz, 2H), 7.91 7.92 (m,
1H), 7.92 8.04 (m, 1H), 8.03 8.09 (m, 1H), 8.10 8.17 (m, 1H), 8.30 (d,
3J(H,H)=8.5 Hz, 2H), 8.81 ppm (brs, 1H); 13C NMR (100 MHz, CDCl3,
258C, TMS): d=93.6, 123.5, 127.3, 127.4, 127.7, 127.9, 128.9, 129.1, 129.1,
129.6, 129.8, 130.0, 130.65, 131.6, 132.5, 136.5, 139.5, 148.0, 182.4,
182.6 ppm; 19F NMR (235 MHz, CDCl3, 258C, CFCl3): d=ꢀ140.185
(75%), ꢀ140.12 ppm (25%); MS (CI, NH3): m/z (%): 416 (100) [M+
+18], 379 (23), 351 (1), 335 (1); elemental analysis calcd (%) for
C25H17BF2O2 (398): C 75.40, H 4.30; found: C 75.20, H 4.31.
Syntheses of the diketones Ar1Ar2 alongpathway B
1-Biphenyl-4’-yl-3-phenylprop-2-enone (1B-BiPhe):[25] Sodium hydroxide
(5m, 4 mL) was slowly added to a heated (508C) solution of benzalde-
hyde (1.06 g, 10 mmol) and 4-acetylbiphenyl (1.96 g, 10 mmol) in ethanol
(50 mL) and THF (10 mL). The mixture was stirred for 20 h at room tem-
perature. After evaporation of the solvents, the residue was extracted
with CH2Cl2. The organic phase was washed several times with water and
was dried (magnesium sulfate). After filtration and evaporation of the
solvent, 1B-BiPhe was obtained as a white solid (2.67 g, 94%) that was
used without further purification for the following step. 1H NMR
(250 MHz, CDCl3, 258C, TMS): d=7.35 7.53 (m, 6H), 7.60 (d,
3J(H,H)=15.7 Hz, 1H), 7.58 7.78 (m, 6H), 7.86 (d, 3J(H,H)=15.7 Hz,
1H), 8.06 8.17 ppm (m, 2H).
Compound 3: Same method as for 1, but with BiPhe (620 mg, 2.1 mmol)
and BF3/Et2O (0.27 mL, 2.1 mmol) in CH2Cl2 (20 mL). 3 was obtained as
orange crystals after recrystallization in benzene (556 mg, 76%). M.p.
2288C; 1H NMR (250 MHz, CDCl3, 258C, TMS): d=7.25 (s, 1H), 7.40
7.63 (m, 5H), 7.63 7.77 (m, 3H), 7.77 7.83 (m, 2H), 8.13 8.21 (m, 2H),
8.21 8.28 ppm (m, 2H); 13C NMR (63 MHz, CDCl3, 258C, TMS): d=
93.3, 127.3, 127.7, 128.9, 129.1, 129.2, 129.6, 130.5, 132.0, 135.2, 139.1,
148.1, 182.7, 182.9 ppm; 19F NMR (235 MHz, CDCl3, 258C, CFCl3): d=
ꢀ140.20 (75%), ꢀ140.14 ppm (25%); MS (CI, NH3): m/z (%): 366 (100)
[M++18], 329 (8), 300 (8), 285 (7); elemental analysis calcd (%) for
C21H15BF2O2 (348): C 72.45, H 4.34; found: C 72.36, H 4.40.
1-(Biphenyl-4-yl)-2,3-dibromo-3-phenylpropanone (2B-BiPhe): An excess
of bromine (0.75 mL, 20 mmol) in CH2Cl2 (7.5 mL) was slowly added at
RT to a solution of 1B-BiPhe (2.67 g, 9.4 mmol) in CH2Cl2 (30 mL).[26]
The mixture was stirred for 80 min. After evaporation of the solvent, 2B-
BiPhe was obtained as a white solid (4.17 g) that was used without fur-
ther purification for the following step. 1H NMR (250 MHz, CDCl3,
258C, TMS): d=5.67 (d, 3J(H,H)=11.3 Hz, 1H), 5.88 (d, 3J(H,H)=
11.3 Hz, 1H), 7.34 7.64 (m, 8H), 7.60 7.70 (m, 2H), 7.72 7.82 (m, 2H),
8.12 8.23 ppm (m, 2H).
Compound 4: Same method as for 1, but with MeOBiPhe (330 mg,
1 mmol) and BF3/Et2O (0.14 mL, 1.1 mmol). 4 was obtained as a yellow
1
powder after recrystallization in benzene (160 mg, 42%). M.p. 2458C; H
NMR (250 MHz, [D6]DMSO, 258C, TMS): d=3.81 (s, 3H), 7.01 7.12 (m,
2H), 7.59 7.72 (m, 2H), 7.77 7.88 (m, 3H), 7.90 8.01 (m,2H), 7.97 (s,
1H), 8.33 8.49 ppm (m, 4H); 13C NMR (63 MHz, [D6]DMSO, 258C,
TMS): d=55.7, 94.7, 115.0, 127.0, 129.0, 129.6, 129.8, 130.6, 130.7, 131.8,
136.1, 147.2, 160.6, 182.2, 182.4 ppm; 19F NMR (235 MHz, CDCl3
(CFCl3), 258C, CFCl3): d=ꢀ140.25 (67%), ꢀ140.19 ppm (33%); MS (CI,
1-(Biphenyl-4-yl)-3-phenylpropane-1,3-dione (BiPhe): Sodium methylate
(460 mg, 18.8 mmol; 2 equiv) in methanol (6 mL) was added to a suspen-
sion of 2B-BiPhe (4.17 g, 9.4 mmol) in methanol (30 mL).[27] After being
1452
¹ 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2004, 10, 1445 1455